JP2005532393A - 眼の障害についての処置 - Google Patents

眼の障害についての処置 Download PDF

Info

Publication number
JP2005532393A
JP2005532393A JP2004519718A JP2004519718A JP2005532393A JP 2005532393 A JP2005532393 A JP 2005532393A JP 2004519718 A JP2004519718 A JP 2004519718A JP 2004519718 A JP2004519718 A JP 2004519718A JP 2005532393 A JP2005532393 A JP 2005532393A
Authority
JP
Japan
Prior art keywords
membrane
bruch
molecule
tissue
individual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004519718A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005532393A5 (enExample
Inventor
ダニエル エム． シュワルツ，
スコット フレイザー，
ロバート エイチ． グラッブス，
ジャスティン ピー． ガリバン，
シー． ジェイ． ユ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California San Diego UCSD
Original Assignee
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California San Diego UCSD filed Critical University of California San Diego UCSD
Publication of JP2005532393A publication Critical patent/JP2005532393A/ja
Publication of JP2005532393A5 publication Critical patent/JP2005532393A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2004519718A 2002-07-02 2003-07-01 眼の障害についての処置 Pending JP2005532393A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39350502P 2002-07-02 2002-07-02
PCT/US2003/020672 WO2004004757A1 (en) 2002-07-02 2003-07-01 Treatment for eye disorder

Publications (2)

Publication Number Publication Date
JP2005532393A true JP2005532393A (ja) 2005-10-27
JP2005532393A5 JP2005532393A5 (enExample) 2006-07-13

Family

ID=30115595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004519718A Pending JP2005532393A (ja) 2002-07-02 2003-07-01 眼の障害についての処置

Country Status (6)

Country Link
US (2) US7381404B2 (enExample)
EP (1) EP1539222A1 (enExample)
JP (1) JP2005532393A (enExample)
CN (1) CN1678342A (enExample)
CA (1) CA2491128A1 (enExample)
WO (1) WO2004004757A1 (enExample)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500382A (ja) * 2006-08-16 2010-01-07 マーリン ニュートラシューティカルズ， インコーポレイテッド 眼疾患の治療
JP2010518903A (ja) * 2007-02-15 2010-06-03 ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン 改善された光退色方法
JP2015527909A (ja) * 2012-07-10 2015-09-24 アイマゴ ソシエテ アノニムＡｉｍａｇｏ Ｓ．Ａ． 灌流評価マルチモダリティ光学医用デバイス
US9757039B2 (en) 2008-07-10 2017-09-12 Ecole Polytechnique Federale De Lausanne (Epfl) Functional optical coherent imaging
WO2018225799A1 (ja) * 2017-06-08 2018-12-13 ウシオ電機株式会社 分光測定方法、分光測定装置及び広帯域パルス光源ユニット
US10169862B2 (en) 2015-05-07 2019-01-01 Novadaq Technologies ULC Methods and systems for laser speckle imaging of tissue using a color image sensor
US10575737B2 (en) 2012-04-27 2020-03-03 Novadaq Technologies ULC Optical coherent imaging medical device
JP2020524061A (ja) * 2017-06-16 2020-08-13 エス． ベルリン、マイケル Ｏｃｔガイド緑内障手術のための方法およびシステム

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532393A (ja) * 2002-07-02 2005-10-27 ザ・リージェンツ・オブ・ジ・ユニバーシティ・オブ・カリフォルニア 眼の障害についての処置
US7727544B2 (en) 2004-05-07 2010-06-01 The Regents Of The University Of California Treatment of myopia
US7654540B2 (en) * 2004-06-18 2010-02-02 Bose Corporation Electromechanical transducing
JP2008510529A (ja) * 2004-08-27 2008-04-10 エレックス メディカル プロプライエタリー リミテッド 選択的眼科レーザ治療
JP2006195240A (ja) * 2005-01-14 2006-07-27 Fuji Photo Film Co Ltd 断層画像化装置
US7668342B2 (en) 2005-09-09 2010-02-23 Carl Zeiss Meditec, Inc. Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
US7768652B2 (en) * 2006-03-16 2010-08-03 Carl Zeiss Meditec, Inc. Methods for mapping tissue with optical coherence tomography data
WO2007143796A1 (en) * 2006-06-15 2007-12-21 Seagull Ip Pty Ltd A delivery system and process
DE102006030382A1 (de) * 2006-06-29 2008-01-03 Carl Zeiss Meditec Ag Verfahren und Vorrichtung zur optischen Detektion am Auge
US8043235B2 (en) * 2006-08-22 2011-10-25 Schwartz Donald N Ultrasonic treatment of glaucoma
AU2007308749B2 (en) 2006-10-25 2013-02-14 Alpharet Pty Ltd Retinal regeneration
JP5656627B2 (ja) * 2007-05-30 2015-01-21 エレックス アールアンドディー プロプライエタリー リミテッドＥｌｌｅｘ Ｒ＆Ｄ Ｐｔｙ Ｌｔｄ 網膜活性化レーザ装置
KR101018785B1 (ko) * 2008-11-28 2011-03-03 삼성전기주식회사 전자기 밴드갭 구조물 및 회로 기판
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US9226654B2 (en) 2011-04-29 2016-01-05 Carl Zeiss Meditec, Inc. Systems and methods for automated classification of abnormalities in optical coherence tomography images of the eye
CN103656621A (zh) * 2013-12-02 2014-03-26 黄丽娜 一种新型鼠神经生长因子玻璃体腔注射给药系统及其应用
CN103705551A (zh) * 2013-12-02 2014-04-09 黄丽娜 一种新型白蒺藜皂苷玻璃体腔注射给药系统及其应用
CN103877430B (zh) * 2014-04-20 2016-04-20 赵华 一种治疗黄斑变性的药物及制备方法
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
CA3052765C (en) * 2017-02-09 2022-07-12 Altregen Co.,Ltd. Composition comprising composite extract from ginseng/red ginseng and sea cucumber as effective ingredient for preventing or treating bruch's membrane hypofunction-related disease

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US220245A (en) * 1879-10-07 Improvement in provision-safes
US6A (en) * 1836-08-10 Thomas Blanchard Machine for forming end pieces of plank blocks for ships
US87985A (en) * 1869-03-16 Improved rotary metal-cotter
US91229A (en) * 1869-06-15 Improvement in feeding-device for machines for combing- cotton
US138329A (en) * 1873-04-29 Improvement in wheel-plows
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
US20030087985A1 (en) 1990-10-15 2003-05-08 Hubbell Jeffrey A. Gels for encapsulation of biological materials
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US5410016A (en) * 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5468505A (en) 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
NZ249770A (en) * 1992-02-28 1996-09-25 Univ Texas Biodegradable, polymerisable, substantially water soluble macromer comprising at least one water soluble region, at least one degradable region and at least two free radical polymerisable regions separated by at least one degradable region
US20040138329A1 (en) 1992-04-20 2004-07-15 Board Of Regents Of The University Of Texas System Gels for encapsulation of biological materials
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene
US5800373A (en) * 1995-03-23 1998-09-01 Focal, Inc. Initiator priming for improved adherence of gels to substrates
US5458505A (en) * 1994-02-03 1995-10-17 Prager; Jay H. Lamp cooling system
US5798349A (en) * 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
US5935942A (en) * 1994-12-14 1999-08-10 Zeimer; Ran Selective and non-invasive visualization or treatment of vasculature
EP0815177B1 (en) * 1995-03-23 2007-08-08 Genzyme Corporation Redox and photoinitiator systems for priming for improved adherence of gels to substrates
US6461640B1 (en) * 1995-12-08 2002-10-08 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
US6059828A (en) * 1996-03-18 2000-05-09 Peyman; Gholam A. Macular indentor for use in the treatment of subretinal neovascular membranes
US6153211A (en) * 1997-07-18 2000-11-28 Infimed, Inc. Biodegradable macromers for the controlled release of biologically active substances
US6128525A (en) * 1997-07-29 2000-10-03 Zeng; Haishan Apparatus and method to monitor photodynamic therapy (PDT)
EP1027016A4 (en) * 1997-10-27 2006-03-08 Univ California METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REFERRING RETINAL RIPPLE
US6472541B2 (en) 1998-11-20 2002-10-29 The Regents Of The University Of California Protecting groups with increased photosensitivities
US6858229B1 (en) * 1999-04-26 2005-02-22 California Institute Of Technology In situ forming hydrogels
DE19920158A1 (de) * 1999-04-29 2000-11-02 Univ Schiller Jena Verfahren und Anordnung zur Bestimmung von Fluorophoren an Objekten, insbesondere am lebenden Augenhintergrund
US6271233B1 (en) * 1999-08-10 2001-08-07 Ciba Vision Corporation Method for treating ocular neovascular diseases
US6267954B1 (en) * 1999-11-24 2001-07-31 Universite De Paris V Rene-Descartes Intraocular transplantation of encapsulated cells
WO2001051087A2 (en) 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
US7291673B2 (en) 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
EP1461028A4 (en) 2001-12-07 2007-07-25 Univ California TREATMENT FOR AGE-RELATED MACULAR AGENCY
JP2005532393A (ja) * 2002-07-02 2005-10-27 ザ・リージェンツ・オブ・ジ・ユニバーシティ・オブ・カリフォルニア 眼の障害についての処置
US20040199130A1 (en) * 2003-04-03 2004-10-07 Chornenky Victor I. Apparatus and method for treatment of macular degeneration

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010500382A (ja) * 2006-08-16 2010-01-07 マーリン ニュートラシューティカルズ， インコーポレイテッド 眼疾患の治療
JP2010518903A (ja) * 2007-02-15 2010-06-03 ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン 改善された光退色方法
JP2014138872A (ja) * 2007-02-15 2014-07-31 Uab Research Foundation 改善された光退色方法のための装置
US9757039B2 (en) 2008-07-10 2017-09-12 Ecole Polytechnique Federale De Lausanne (Epfl) Functional optical coherent imaging
US10617303B2 (en) 2008-07-10 2020-04-14 Ecole Polytechnique Federale De Lausanne (Epfl) Functional optical coherent imaging
US10575737B2 (en) 2012-04-27 2020-03-03 Novadaq Technologies ULC Optical coherent imaging medical device
JP2015527909A (ja) * 2012-07-10 2015-09-24 アイマゴ ソシエテ アノニムＡｉｍａｇｏ Ｓ．Ａ． 灌流評価マルチモダリティ光学医用デバイス
US10101571B2 (en) 2012-07-10 2018-10-16 Novadaq Technologies ULC Perfusion assessment multi-modality optical medical device
US10169862B2 (en) 2015-05-07 2019-01-01 Novadaq Technologies ULC Methods and systems for laser speckle imaging of tissue using a color image sensor
WO2018225799A1 (ja) * 2017-06-08 2018-12-13 ウシオ電機株式会社 分光測定方法、分光測定装置及び広帯域パルス光源ユニット
US11300452B2 (en) 2017-06-08 2022-04-12 Ushio Denki Kabushiki Kaisha Spectral measurement method, spectral measurement system, and broadband pulsed light source unit
US12359971B2 (en) 2017-06-08 2025-07-15 Ushio Denki Kabushiki Kaisha Spectral measurement method, spectral measurement system, and broadband pulsed light source unit
JP2020524061A (ja) * 2017-06-16 2020-08-13 エス． ベルリン、マイケル Ｏｃｔガイド緑内障手術のための方法およびシステム

Also Published As

Publication number Publication date
CA2491128A1 (en) 2004-01-15
CN1678342A (zh) 2005-10-05
WO2004004757A8 (en) 2004-10-07
US7381404B2 (en) 2008-06-03
WO2004004757A1 (en) 2004-01-15
US20050048044A1 (en) 2005-03-03
US8298521B2 (en) 2012-10-30
EP1539222A1 (en) 2005-06-15
US20080286255A1 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
US8298521B2 (en) Treatment for eye disorder
US6984655B1 (en) Photodynamic therapy for selectively closing neovasa in eyeground tissue
US20070027101A1 (en) Methods for treating ocular neovascular diseases
JP2007536272A (ja) 近視の処置法
JPH08502033A (ja) ＴＧＦ−βを用いる眼疾患の治療方法
WO1995024930A1 (en) Use of green porphyrins in ocular diagnosis and therapy
JP2005535691A (ja) 加齢性黄斑変性を有する患者における視力の保護のための酢酸アネコルタブの使用
Tarantola et al. Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy
Spaide Central serous chorioretinopathy
Singh et al. The use of dye in ophthalmology
AU2003253767A1 (en) Treatment for eye disorder
KR20050021375A (ko) 안질환의 치료 방법
RU2682496C1 (ru) Способ лазерного лечения хронической рецидивирующей центральной серозной хориоретинопатии
JP2004530645A (ja) 特定の眼疾患の処置方法
EP4186524A1 (en) Prevention and/or treatment of eye disease by collagen fiber crosslinking
Oguz Mitomycin C and pterygium excision
WO2024259148A2 (en) Increasing adhesion between vitreous and retina
RU2290973C1 (ru) Способ лечения субретинальной неоваскулярной мембраны
Elfervig et al. Retinal detachment
Rahman et al. Charles Bonnet syndrome and brimonidine: comments
RU2318479C1 (ru) Способ лечения отслоек цилиарного тела
CN117479932A (zh) 用于退行性视网膜疾病的吡唑啉酮化合物
HK40007309A (en) Treatment for myopia
Nao-I Pearls in the management of macular holes
Khong et al. Transcaruncular approach for the management of frontoethmoidal mucoceles: a comment

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060529

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090717

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091209